Highlights
NASDAQ: OMER       Omeros Corp
Last Price Today's Change   Day's Range   Trading Volume
20.41   +0.95 (4.88%)  19.87 - 20.669  513,516

Overview

 
Avg Volume (4 weeks):741,129
4 Weeks Range:14.03 - 20.669
4 Weeks Price Volatility (%):
96.10%
52 Weeks Range:8.50 - 25.46
52 Weeks Price Volatility (%):
70.22%
Average Price Target: 30.00
Price Target Upside/Downside: +9.59

Headlines



No recent Headlines for this stock.


Business Background

Omeros Corp is a United States based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3112  3200  337  3256 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 OBLN 4.55+2.94 
 AMC 2.815-0.245 
 CTRM 0.317-0.024 
 CLBS 3.78+2.15 
 BNGO 7.64-1.50 
 SNDL 0.692+0.002 
 GEVO 8.32-2.71 
 ADMP 1.338+0.532